Results 141 to 150 of about 1,322,570 (292)
Managing Diabetic Patients during the Coronavirus Disease (COVID-19) Pandemic [PDF]
, 2020 Ghada Mohammed Ahmed
openalex +1 more source
Delirium Secondary to Coronavirus Disease 2019: A Case Series [PDF]
, 2021 Allison Parrill +4 more
openalex +1 more source
British Journal of Clinical Pharmacology, EarlyView.Abstract Aims Paroxetine is a selective serotonin reuptake inhibitor (SSRI), approved for treatment of major depressive disorder and anxiety disorders. Some SSRIs are known to prolong the QT interval; however, clinical evidence to establish a lack of association between paroxetine and corrected QT interval (QTc) prolongation is limited. Therefore, this
Sven C. van Dijkman +6 more
wiley +1 more source
Coronavirus pandemic in Slovakia – The National Library’s experience [PDF]
, 2020 Kristofova Katarina
openalex +1 more source
The Association between Weather Conditions (Ambient Air Temperature and Relative Humidity) with Coronavirus Disease (COVID-19) Risk in Bandar Abbas, Iran [PDF]
, 2021 Yadolah Fakhri +3 more
openalex +1 more source
Intravenous lanadelumab for the treatment of moderately ill COVID‐19 patients
British Journal of Clinical Pharmacology, EarlyView.Aims Kallikrein‐kinin system (KKS) dysregulation is hypothesized to play a pathogenetic role in COVID‐19‐associated pulmonary oedema. To investigate the efficacy and safety of intravenous lanadelumab, a monoclonal antibody that inhibits plasma kallikrein, in COVID‐19, we conducted a phase 2, open‐label, randomized‐controlled, proof‐of‐concept ...
Job J. Engel +12 more
wiley +1 more source